Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Medicine

• Publication date

  1995-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9343(99)80182-XPMID 7573090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Dyslipidemia in IPPM Patients

  1994cited by this paper
• A multinational study of the effects of low‐dose pravastatin in patients with non‐insulin‐dependent diabetes mellitus and hypercholesterolemia

  1994cited by this paper
• Long-term complications of diabetes mellitus.

  1993cited by this paper
• Understanding and Treating Dyslipidemia Associated With Noninsulin‐Dependent Diabetes Mellitus and Hypertension

  1993cited by this paper
• Detection and management of lipid disorders in diabetes. American Diabetes Association.

  1993cited by this paper
• Treatment of hyperlipidemia in the nephrotic syndrome: the effects of pravastatin therapy.

  1993cited by this paper
• Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.

  1993cited by this paper
• Long-term experience with pravastatin in clinical research trials.

  1993cited by this paper
• Simvastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus and in primary hyperocholesterolemia

  1992cited by this paper
• Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.

  1992cited by this paper
• Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study

  1992cited by this paper
• Detection and Management of Lipid Disorders in Diabetic Patients: A commentary for clinicians

  1992cited by this paper
• Lipid-Lowering Therapy and Macrovascular Disease in Diabetes Mellitus

  1992cited by this paper
• Long-term treatment with simvastatin in hypercholesterolemic non-insulin-dependent diabetic patients

  1992cited by this paper
• Atherogenesis in diabetes

  1992cited by this paper
• Comparison of the effects of small doses of probucol and pravastatin on serum lipids and apolipoproteins in nonobeses, non-insulin-dependent diabetes mellitus patients with hypercholesterolemia

  1992cited by this paper
• George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.

  1992cited by this paper
• The effects of lipid lowering on diabetic retinopathy.

  1991cited by this paper
• The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group.

  1991cited by this paper
• Lipoprotein Physiology in Nondiabetic and Diabetic States: Relationship to Atherogenesis

  1991cited by this paper
• Decreased albuminuria by pravastatin in hyperlipidemic diabetics.

  1991cited by this paper
• A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

  1991cited by this paper
• Trends in Prevalence of Diabetes Mellitus in Patients with Myocardial Infarction and Effect of Diabetes on Survival: The Minnesota Heart Survey

  1991cited by this paper
• Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus.

  1991cited by this paper
• Once‐daily pravastatin in patients with primary hypercholesterolemia: A dose‐response study

  1991cited by this paper
• Effects of lovastatin in diabetic patients treated with chlorpropamide

  1990cited by this paper
• Management of Dyslipidemia in NIDDM

  1990cited by this paper
• Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.

  1990cited by this paper
• Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus.

  1990cited by this paper
• Sulfonylureas Why, Which, and How?

  1990cited by this paper
• Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey.

  1989cited by this paper
• Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease risk.

  1989cited by this paper
• Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease — putative association via common antecedents; further evidence from the whitehall study

  1988cited by this paper
• Cholestyramine Improves Glycemic Control in Diabetic Patients

  1988cited by this paper
• Lipoprotein metabolism in diabetes mellitus.

  1987cited by this paper
• A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study.

  1986cited by this paper
• Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

  1985cited by this paper
• Lipoprotein Composition in Individuals with Impaired Glucose Tolerance

  1983cited by this paper
• Plasma lipids and diabetes mellitus in an adult community.

  1982cited by this paper
• Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

  1979cited by this paper
• Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study

  1974cited by this paper

• Antidiabetic Activity (Anti-Hyperglycemic Activity, Anti-Hyperlipidemic Activity)/Agents From Medicinal Plants

  2020cites this paper
• Type 1 Diabetes in Adults

  2010cites this paper
• Statin Adverse Effects

  2008cites this paper
• Diabetes: managing dyslipidaemia.

  2008cites this paper
• Efficacy and safety of high‐dose pravastatin in hypercholesterolemic patients with well‐compensated chronic liver disease: Results of a prospective, randomized, double‐blind, placebo‐controlled, multicenter trial

  2007cites this paper
• Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.

  2005cites this paper
• of the National Heart , Lung , and Blood Institute – National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus

  2005cites this paper
• Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.

  2004cites this paper
• Compliance with National Guidelines in Patients with Diabetes in a Family Practice Clinic

  2002cites this paper
• Current Lipid-lowering Strategies for the Treatment of Diabetic Dyslipidemia: An Integrated Approach to Therapy

  2001cites this paper
• Pharmaco-Economic Impact of HMG-CoA Reductase Inhibitors in Type 2 Diabetes

  2001cites this paper
• Insulin resistance syndrome and type 2 diabetes mellitus.

  2001cites this paper
• Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins.

  2001cites this paper
• [Statins and diabetic hyperlipidemia].

  2001cites this paper
• HMG‐CoA reductase inhibition protects the diabetic myocardium from ischemia‐reperfusion injury

  2001cites this paper
• Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study.

  2000cites this paper
• Effects of pravastatin treatment on lipoprotein levels and composition in patients with type 2 diabetes mellitus and hypercholesterolemia

  2000cites this paper
• Comparative Tolerability of the HMG-CoA Reductase Inhibitors

  2000cites this paper
• Efficacy and Safety of Cerivastatin for Type 2 Diabetes and Hypercholesterolemia

  1999cites this paper
• Efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolaemia. Hyperlipidaemia in Diabetes Mellitus investigators.

  1999cites this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cites this paper
• Methods of literature review and synthesis.

  1998cites this paper
• Drug Administration in Patients with Diabetes Mellitus

  1998cites this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cites this paper
• Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials.

  1997cites this paper
• Pravastatin in diabetes-associated hypercholesterolemia

  1997cites this paper
• Primer Hiperlipidemide Kolestiramin ve Pravastatinin Karşılaştırılması; Kolestiramin-Pravastatin Kombinasyonunun Etkinliği

  1996cites this paper
• Insulin Resistance and Lipoproteins in Hypertriglyceridemia: Effects of Hypolipidemic Drug Treatment

  1996cites this paper
• Diabetic dyslipidemia: effects of diabetes control, diet and drug therapy.

  1996cites this paper